Proof-of-concept Studies for siRNA-mediated Gene Silencing for Coagulation Factors in Rat and Rabbit-Reference-Cited by-同舟云学术

Proof-of-concept Studies for siRNA-mediated Gene Silencing for Coagulation Factors in Rat and Rabbit

Published:2015 Issue: Volume:4 Page:e224
ISSN:2162-2531
Container-title:Molecular Therapy - Nucleic Acids
language:en
Short-container-title:Molecular Therapy - Nucleic Acids

Author:

Chen Zhu,Luo Bin,Cai Tian-Quan,Thankappan Anil,Xu Yiming,Wu Weizhen,DiMuzio Jillian,Lifsted Traci,DiPietro Marty,Disa Jyoti,Ng Bruce,Leander Karen,Clark Seth,Hoos Lizbeth,Zhou Yuchen,Jochnowitz Nina,Jachec Christine,Szczerba Peter,Gindy Marian E,Strapps Walter,Sepp-Lorenzino Laura,Seiffert Dietmar A,Lubbers Laura,Tadin-Strapps Marija

Publisher

Elsevier BV

Subject

Drug Discovery,Molecular Medicine

Reference38 articles.

1. siRNA therapeutics in the treatment of diseases;Bakhtiyari;Ther Deliv,2013

2. siRNA-induced liver ApoB knockdown lowers serum LDL-cholesterol in a mouse model with human-like serum lipids;Tadin-Strapps;J Lipid Res,2011

3. Targeting of hepatic angiotensinogen using chemically modified siRNAs results in significant and sustained blood pressure lowering in a rat model of hypertension;Olearczyk;Hypertens Res,2014

4. Acute and severe coagulopathy in adult mice following silencing of hepatic antithrombin and protein C production;Safdar;Blood,2013

5. Rescue of Mtp siRNA-induced hepatic steatosis by DGAT2 siRNA silencing;Tep;J Lipid Res,2012

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring dose and downregulation dynamics in lipid nanoparticles based siRNA therapy: Systematic review and meta-analysis;International Journal of Biological Macromolecules;2024-10

2. Influence of Surface-Modification via PEGylation or Chitosanization of Lipidic Nanocarriers on In Vivo Pharmacokinetic/Pharmacodynamic Profiles of Apixaban;Pharmaceutics;2023-06-07

3. Tailoring Apixaban in Nanostructured Lipid Carrier Enhancing Its Oral Bioavailability and Anticoagulant Activity;Pharmaceutics;2022-12-27

4. One night of sleep deprivation induces release of small extracellular vesicles into circulation and promotes platelet activation by small EVs;Journal of Cellular and Molecular Medicine;2022-08-31

5. Milvexian, an orally bioavailable, small‐molecule, reversible, direct inhibitor of factor XIa: In vitro studies and in vivo evaluation in experimental thrombosis in rabbits;Journal of Thrombosis and Haemostasis;2021-11-24